YS Biopharma | SC 13G/A:大量保有報告書(訂正)-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%)など
YS Biopharma | SC 13G:大量保有報告書-Yi ZHANG(42.6%),All Brilliance Investments Limited(41.9%)など
YS Biopharma | SC 13D:大量保有報告書-Fung Ching Wong(52.23%),Apex Prospect Limited(52.23%)
Summit Healthcare Acquisition Corp | SC 13G:大量保有報告書-Glazer Capital, LLC(8.68%),Paul J. Glazer(8.68%)
Summit Healthcare Acquisition Corp | SC 13G/A:大量保有報告書(訂正)
Summit Healthcare Acquisition Corp | SC 13G:大量保有報告書-Aristeia Capital, L.L.C.(8.05%)
Summit Healthcare Acquisition Corp | SC 13G/A:大量保有報告書(訂正)-Millennium Management LLC(5.6%),Millennium Group Management LLC(5.6%)など
Summit Healthcare Acquisition Corp | SC 13G/A:大量保有報告書(訂正)-BFAM Partners (Cayman) Limited(0%),BFAM Partners (Hong Kong) Limited(0%)など
Summit Healthcare Acquisition Corp | SC 13G:大量保有報告書: 大量保有報告書-Cantor Fitzgerald Securities(5.15%),Cantor Fitzgerald, L.P.(5.15%)など
Summit Healthcare Acquisition Corp | SC 13G/A:大量保有報告書(訂正): 大量保有報告書(訂正)-BFAM Partners (Cayman) Limited(5.5%),BFAM Partners (Hong Kong) Limited(5.5%)など
Summit Healthcare Acquisition Corp | SC 13G/A:大量保有報告書(訂正): 大量保有報告書(訂正)-BFAM Partners (Cayman) Limited(5.6%),BFAM Partners (Hong Kong) Limited(5.6%)など
Summit Healthcare Acquisition Corp | SC 13G:大量保有報告書: 大量保有報告書-Summit Healthcare Acquisition Sponsor LLC(20.58%)
Summit Healthcare Acquisition Corp | SC 13G/A:大量保有報告書(訂正): 大量保有報告書(訂正)-Millennium Management LLC(6.0%),Millennium Group Management LLC(6.0%)など
Summit Healthcare Acquisition Corp | SC 13G:大量保有報告書
Summit Healthcare Acquisition Corp | SC 13G:大量保有報告書
Summit Healthcare Acquisition Corp | 3:インサイダー登録報告書
Summit Healthcare Acquisition Corp | 3:インサイダー登録報告書
Summit Healthcare Acquisition Corp | 3:インサイダー登録報告書
Summit Healthcare Acquisition Corp | 3:インサイダー登録報告書
Summit Healthcare Acquisition Corp | 3:インサイダー登録報告書
データなし